UK mRNA Synthesis & Manufacturing Market (2024-2029)
The UK mRNA Synthesis & Manufacturing Market was valued at $85.8 Million in 2024 and projected to reach to $108.2 Million by 2029, representing a compound annual growth rate of 4.7%. The UK mRNA synthesis and manufacturing market is poised for sustained growth through 2029, supported by continued government investment in life sciences and the country's established regulatory framework.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK mRNA Synthesis & Manufacturing Market Trends and Insights
- The UK's robust pharmaceutical infrastructure, coupled with government support for life sciences innovation, positions the country as a key hub for mRNA technology development and production.
- The UK's established regulatory framework and investment in biotech capabilities are driving adoption of advanced mRNA manufacturing platforms. During the 2024-2029 forecast period, the UK market will benefit from increased demand for mRNA-based therapeutics and vaccines, alongside growing contract manufacturing organization (CMO) capacity.
- The UK's commitment to becoming a global life sciences leader has accelerated infrastructure development and attracted significant private and public investment.
- Key drivers include expanding clinical pipelines, rising manufacturing capacity, and strengthened supply chain resilience across the UK biotech sector..
Key Market Statistics
- CAGR (2024-2029) 4.7% CAGR
- Market Size, 2024 ~USD 85.8 Million
- Forecast, 2029 ~USD 108.2 Million
- Country UK
UK mRNA Synthesis & Manufacturing Market Overview
Market Valuation :
The UK mRNA synthesis and manufacturing market reached $85.8 million in 2024, with projections to grow to $108.2 million by 2029, driven by increasing demand for mRNA-based therapeutics and vaccines.
Government Support & Infrastructure :
The UK government's commitment to life sciences innovation, combined with world-class pharmaceutical infrastructure and research institutions, creates a favorable environment for mRNA technology development and commercialization.
Strategic Hub Status :
The UK has established itself as a key European hub for mRNA technology, attracting significant investment from global biotech companies and fostering collaboration between academia, industry, and regulatory bodies.
Growth Trajectory :
With a CAGR of 4.7% through 2029, the UK market demonstrates steady expansion, outpacing broader economic growth and reflecting strong confidence in mRNA-based therapeutic development and manufacturing capabilities.
UK mRNA Synthesis & Manufacturing Market Dynamics
- The presence of leading research institutions, contract manufacturing organizations, and biopharmaceutical companies creates a robust ecosystem for mRNA innovation.
- Increasing applications beyond COVID-19 vaccines, including personalized cancer therapies and rare disease treatments, are expanding market opportunities.
- The UK's strategic position as a bridge between European and global markets enhances its attractiveness for mRNA manufacturing investments and partnerships. Looking ahead, the market will benefit from technological advancements in synthesis efficiency, cost reduction initiatives, and expanded manufacturing capacity.
- Post-Brexit regulatory independence has enabled the UK to streamline approval processes for mRNA therapeutics, potentially accelerating time-to-market.
- Collaborations between UK institutions and international partners, combined with growing venture capital interest in mRNA platforms, are expected to drive innovation and market expansion through the forecast period..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- The UK mRNA synthesis & manufacturing market is valued at $85.8M in 2024 and will reach $108.2M by 2029 at a 4.7% CAGR.
- The UK's regulatory expertise and government life sciences strategy are accelerating mRNA manufacturing capacity expansion.
- Growing clinical pipelines and CMO partnerships are driving demand for UK-based mRNA synthesis services.
- The UK's focus on supply chain resilience and biotech investment positions it as a competitive European mRNA hub.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
UK mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 27.5 | 20.1 | 20.2 | 20.8 | 21.8 | 22.8 | 23.9 | 25.3 | 4.7 |
| CROS & CDMOS | 24.1 | 17.6 | 17.7 | 18.2 | 19.1 | 19.9 | 20.9 | 22.1 | 4.6 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 65.2 | 47.7 | 48 | 49.7 | 52.1 | 54.6 | 57.3 | 60.8 | 4.8 |
| TOTAL | 116.7 | 85.4 | 85.8 | 88.7 | 93 | 97.4 | 102 | 108.2 | 4.7 |
UK: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 14.5 | 12.6 | 12.7 | 13.2 | 14.1 | 15 | 16.2 | 17.8 | 7 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 41.8 | 36.3 | 36.7 | 38.4 | 41 | 44.1 | 47.7 | 52.6 | 7.5 |
| SMALL-SCALE CROS & CDMOS | 5.4 | 4.7 | 4.7 | 4.8 | 5.1 | 5.4 | 5.8 | 6.3 | 6.2 |
| TOTAL | 61.7 | 53.6 | 54 | 56.5 | 60.2 | 64.6 | 69.7 | 76.7 | 7.2 |
Target Audience
- Pharmaceutical & Biotech Companies : UK-based and international pharma firms seeking to establish or expand mRNA manufacturing capabilities need detailed market data to guide investment decisions, facility planning, and competitive positioning.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in or targeting the UK market require comprehensive market analysis to identify growth opportunities, capacity planning needs, and client acquisition strategies in the mRNA sector.
- Investment & Venture Capital Firms : Investors evaluating opportunities in UK life sciences and mRNA technology need market-specific data to assess portfolio companies, identify funding gaps, and evaluate return potential in the region.
- Government & Policy Makers : UK government agencies and policy bodies benefit from detailed market intelligence to inform life sciences strategy, funding allocation, and regulatory framework development supporting mRNA innovation.
- Research Institutions & Academics : Universities and research centers in the UK need market insights to align research initiatives with commercial opportunities, secure funding, and establish industry partnerships in mRNA development.
Reasons to Buy this Report
- UK-Specific Market Sizing : Obtain precise valuation data for the UK mRNA synthesis and manufacturing market with detailed historical performance and forward projections through 2029, enabling accurate business planning and investment decisions.
- Competitive Landscape Intelligence : Understand the UK's unique competitive positioning within Europe, identify key players operating in the region, and assess market consolidation trends specific to British mRNA manufacturing.
- Regulatory & Policy Insights : Gain comprehensive analysis of UK-specific regulatory frameworks, post-Brexit advantages, government support programs, and policy initiatives driving mRNA sector growth and manufacturing investments.
- Investment & Growth Opportunities : Identify high-potential segments, emerging applications, and geographic expansion opportunities within the UK market, supported by detailed CAGR analysis and trend forecasting through 2029.
- Strategic Partnership Mapping : Access insights into UK research institutions, contract manufacturers, and industry collaborations to inform partnership strategies, licensing opportunities, and market entry approaches.
Frequently asked questions
What is the current size of the UK mRNA synthesis & manufacturing market?
The UK mRNA synthesis & manufacturing market was valued at $85.8 million in 2024.
What is the projected market size for the UK by 2029?
The UK market is forecast to reach $108.2 million by 2029, growing at a 4.7% CAGR.
What factors are driving growth in the UK mRNA manufacturing sector?
Key drivers include government life sciences investment, expanding clinical pipelines, growing CMO capacity, and regulatory expertise supporting mRNA technology adoption across the UK.
How does the UK mRNA market compare to global growth rates?
The UK market is growing at 4.7% CAGR, slightly below the global average of 5.8%, reflecting a mature but stable market with strong regulatory foundations.
Which segments are most active in the UK mRNA manufacturing market?
Contract manufacturing organizations, vaccine developers, and therapeutic companies are the primary segments driving demand for mRNA synthesis services in the UK.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
